These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5527950)

  • 1. Insulin and insulin effect in a she-dog with spontaneous diabetes.
    Fischer U; Hommel H; Knospe S; Michael R; Ziegler M
    Horm Metab Res; 1970 Jul; 2(4):251-2. PubMed ID: 5527950
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin in the pancreatic blood and insulin half-life in an Alsatian bitch with spontaneous diabetes.
    Hommel H; Fischer U; Kansy H
    Horm Metab Res; 1971 May; 3(3):213-4. PubMed ID: 5123999
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma insulin, glucagon, and nonesterified fatty acids in dogs with diabetes mellitus.
    Manns JG; Martin CL
    Am J Vet Res; 1972 May; 33(5):981-5. PubMed ID: 5023056
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-induced hyperglycemia in diabetic dogs.
    Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1982 Jun; 180(12):1432-7. PubMed ID: 7047478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the effect of thyroxine replacement therapy on the increased insulin response to hyperglycemia in the thyroidectomized dog.
    Renauld A; Sverdlik RC; Andrade LL; Rodríguez RR
    Horm Metab Res; 1972 Sep; 4(5):373-6. PubMed ID: 4645933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
    Herrlinger H; Dörfler H; Wolfram G; Zöllner N
    Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum immunoreactive insulin in the hypophysectomized dog. Effect of cortisol replacement therapy.
    Renauld A; Pinto JE; Christensen AF; Sverdlik RC; Foglia VG
    Horm Metab Res; 1970 May; 2(3):157-60. PubMed ID: 5521403
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroidectomy and cortisol therapy. Their effects on blood sugar, serum immunoreactive insulin and free fatty acids during an oral glucose tolerance test.
    Renauld A; Sverdlik RC; Foglia VG
    Acta Physiol Lat Am; 1974; 24(2):143-52. PubMed ID: 4451125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical testing of Ro 6-4563--a new peroral anti-diabetic preparation].
    Berchtold P; Fagerberg SE
    Lakartidningen; 1971 Sep; 68(40):4503-7. PubMed ID: 4944538
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of insulin therapy in canine diabetes mellitus.
    Nelson RW; Feldman EC
    J Am Vet Med Assoc; 1983 Jun; 182(12):1321-5. PubMed ID: 6348002
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
    Lecomte MJ; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
    [No Abstract]   [Full Text] [Related]  

  • 13. Transient insulin response in dogs and cats with diabetes mellitus.
    Schaer M
    J Am Vet Med Assoc; 1976 Mar; 168(5):417-8. PubMed ID: 1254514
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of testosterone on blood sugar, serum insulin and free fatty acid responses to glucose in normal male dog.
    Renauld A; Sverdlik RC
    Acta Physiol Lat Am; 1975; 25(5):423-9. PubMed ID: 1235026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 16. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glaucoma and diabetes].
    Doden W; Alpers K
    Wien Klin Wochenschr; 1968 Jun; 80(24):471-3. PubMed ID: 5679744
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum insulin and free fatty acid responses to slow and quick graded hyperglycaemias in hypothyroid dogs.
    Renauld A; Andrade LL; Sverdlik RC; Rodríquez RR; Lindental DM
    Horm Metab Res; 1979 Apr; 11(4):265-70. PubMed ID: 457029
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.